ELICIO THERAPEUTICS INC (ELTX) Forecast, Price Target & Analyst Ratings

NASDAQ:ELTX • US28657F1030

Current stock price

12.46 USD
+0.68 (+5.77%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ELICIO THERAPEUTICS INC (ELTX).

Forecast Snapshot

Consensus Price Target

Price Target
$17.85
+ 43.26% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 11, 2026
Period
Q1 / 2026
EPS Estimate
-$0.50
Revenue Estimate
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
82.50%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$17.85
Upside
+ 43.26%
From current price of $12.46 to mean target of $17.85, Based on 8 analyst forecasts
Low
$17.17
Median
$17.85
High
$18.90

Price Target Revisions

1 Month
12.90%
3 Months
12.90%

Price Target Summary

8 Wall Street analysts provided a forecast for the next 12 months for ELTX. The average price target is 17.85 USD. This implies a price increase of 43.26% is expected in the next year compared to the current price of 12.46.
The average price target has been revised upward by 12.9% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

ELTX Current Analyst RatingELTX Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4

Analyst Ratings History

ELTX Historical Analyst RatingsELTX Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8

Analyst Ratings Consensus

ChartMill Buy Consensus
82.50%
ELTX was analyzed by 8 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about ELTX.
In the previous month the buy percentage consensus was at a similar level.
ELTX was analyzed by 8 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-04-15Ladenburg ThalmannInitiate Buy
2026-03-13HC Wainwright & Co.Maintains Buy -> Buy
2026-03-10Rodman & RenshawInitiate Buy
2025-07-17HC Wainwright & Co.Maintains Buy -> Buy
2025-04-02HC Wainwright & Co.Reiterate Buy -> Buy
2024-10-31Jones TradingInitiate Buy
2024-08-23HC Wainwright & Co.Reiterate Buy -> Buy
2024-06-06HC Wainwright & Co.Reiterate Buy -> Buy
2024-05-22HC Wainwright & Co.Reiterate Buy -> Buy
2024-05-01HC Wainwright & Co.Maintains Buy -> Buy
2024-04-01OppenheimerReiterate Perform -> Perform
2024-01-17HC Wainwright & Co.Maintains Buy -> Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 11, 2026
Period
Q1 / 2026
EPS Estimate
-$0.50
Revenue Estimate
Revenue Q2Q
N/A
EPS Q2Q
42.55%
Number of Analysts
4

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
-16.67%
EPS (3 Months)
-16.67%

Next Earnings Summary

ELTX is expected to report earnings on 5/11/2026. The consensus EPS estimate for the next earnings is -0.5 USD and the consensus revenue estimate is 0 USD.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2032

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
ELTX revenue by date.ELTX revenue by date.
2.88M
93.29%		28.31M
882.99%		2.3M
-91.88%
-100.00%		1.02M5.1M
400.00%		12.24M
140.00%		20.4M
66.67%
EBITDA
YoY % growth
ELTX ebitda by date.ELTX ebitda by date.
-55.17M
-43.15%		-39.22M
28.91%		-30.25M
22.87%		-41.83M
-16.90%		-46.657M
-26.34%		N/AN/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
ELTX ebit by date.ELTX ebit by date.
-55.27M
-43.22%		-39.31M
28.88%		-30.43M
22.59%		-31.405M
-17.47%		-43.247M
-25.89%		-37.55M
16.55%		-35.08M
6.58%		-36.72M
-4.67%		-44.064M
-20.00%		N/AN/AN/AN/A
Operating Margin
ELTX operating margin by date.ELTX operating margin by date.
-1,919.10%-138.86%-1,323.04%N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
ELTX eps by date.ELTX eps by date.
N/A-20.90
64.67%		-12.90
38.28%		-5.56
56.91%		-4.15
24.45%		-2.56
38.57%		-1.73
32.79%		-1.43
17.65%		-1.48
-3.57%		N/AN/AN/AN/A

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth		-0.50
42.55%		-0.44
33.55%		-0.40
33.70%		-0.41
9.33%
Revenue
Q2Q % growth
EBITDA
Q2Q % growth		N/AN/AN/AN/A
EBIT
Q2Q % growth		-9.161M
14.67%		-9.305M
7.78%		-9.452M
-17.49%		-9.602M
-8.60%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

ELTX Yearly Revenue VS EstimatesELTX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2029 2030 2031 2032 5M 10M 15M 20M 25M
ELTX Yearly EPS VS EstimatesELTX Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 -10 -20 -30 -40 -50

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
12.58%
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

ELICIO THERAPEUTICS INC / ELTX Forecast FAQ

What do analysts expect the price target to be for ELICIO THERAPEUTICS INC (ELTX)?

8 analysts have analysed ELTX and the average price target is 17.85 USD. This implies a price increase of 43.26% is expected in the next year compared to the current price of 12.46.

Can you provide the upcoming earnings date for ELICIO THERAPEUTICS INC?

ELICIO THERAPEUTICS INC (ELTX) will report earnings on 2026-05-11.

What are the consensus estimates for ELTX stock next earnings?

The consensus EPS estimate for the next earnings of ELICIO THERAPEUTICS INC (ELTX) is -0.5 USD and the consensus revenue estimate is 0 USD.